78 related articles for article (PubMed ID: 7795731)
1. Nuclear characterization and G2M ploidy in human brain tumors using semiautomated image analysis.
Yoshii Y; Saito A; Tsuboi K; Tsurushima H; Komatsu Y; Tomono Y; Hyodo A; Nose T
Noshuyo Byori; 1995 Mar; 12(1):61-7. PubMed ID: 7795731
[TBL] [Abstract][Full Text] [Related]
2. Nuclear morphometry and DNA densitometry of human gliomas by image analysis.
Yoshii Y; Saito A; Nose T
J Neurooncol; 1995 Oct; 26(1):1-9. PubMed ID: 8583239
[TBL] [Abstract][Full Text] [Related]
3. Image analysis of nuclear DNA content and morphometric characteristics of the tumor cells in human astrocytomas.
Saito A; Yoshii Y; Nose T
Noshuyo Byori; 1994; 11(2):143-6. PubMed ID: 7894615
[TBL] [Abstract][Full Text] [Related]
4. Proliferative characteristics and ploidy of human brain tumors by DNA flow cytometry.
Danova M; Riccardi A; Mazzini G; Ucci G; Montecucco CM; Gaetani P; Silvani V; Knerich R; Butti G; Ascari E
Basic Appl Histochem; 1986; 30(2):175-80. PubMed ID: 3741314
[TBL] [Abstract][Full Text] [Related]
5. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
6. [Flow cytometric studies of human brain tumors. Part I: Human malignant brain tumors (author's transl)].
Kawamoto K; Nishiyama T; Ikeda Y; Yamanouchi Y; Kawamura Y; Matsumura H; Hirano A; Herz F; Wolley RC
No Shinkei Geka; 1980 Aug; 8(8):723-8. PubMed ID: 6999372
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy and proliferation heterogeneity in human prostate cancers.
Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
[TBL] [Abstract][Full Text] [Related]
8. DNA ploidy status and DNA content instability within single tumors in renal cell carcinoma.
Bringuier PP; Bouvier R; Berger N; Piaton E; Revillard JP; Perrin P; Devonec M
Cytometry; 1993; 14(5):559-64. PubMed ID: 8354129
[TBL] [Abstract][Full Text] [Related]
9. S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
Struikmans H; Rutgers DH; Jansen GH; Tulleken CA; van der Tweel I; Battermann JJ
Radiat Oncol Investig; 1997; 5(4):170-9. PubMed ID: 9327496
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of DNA content and nuclear morphology in borderline ovarian tumors.
Drescher CW; Flint A; Hopkins MP; Roberts JA
Gynecol Oncol; 1993 Feb; 48(2):242-6. PubMed ID: 8428698
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy and nuclear morphometry in adult intracranial ependymomas.
Onguru O; Ulutin C; Celasun B; Gunhan O
Clin Neuropathol; 2003; 22(6):266-72. PubMed ID: 14672504
[TBL] [Abstract][Full Text] [Related]
12. Relationship between DNA ploidy level and tumor sociology behavior in 12 nervous cell lines.
Kiss R; Camby I; Salmon I; Van Ham P; Brotchi J; Pasteels JL
Cytometry; 1995 Jun; 20(2):118-26. PubMed ID: 7664622
[TBL] [Abstract][Full Text] [Related]
13. Characterization of nuclear size, ploidy, DNA histogram type and proliferation index in 79 nerve sheath tumors.
Salmon I; Kiss R; Segers V; Carroyer JM; Levivier M; Pasteels JL; Brotchi J; Flament-Durand J
Anticancer Res; 1992; 12(6B):2277-83. PubMed ID: 1295475
[TBL] [Abstract][Full Text] [Related]
14. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
15. Ploidy study in oral carcinomas: use of improved methodology to assess its clinical prognostic value.
Brandizzi D; Lanfranchi HE; Cabrini RL
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):406-12. PubMed ID: 19716508
[TBL] [Abstract][Full Text] [Related]
16. [Determination of malignancy of cartilaginous tumors (2). Determination of malignancy by nuclear DNA contents and their distribution patterns in cartilaginous tumors].
Lin CP; Higaki S; Takeyama S; Nakata T; Akai M; Tateishi A; Abe M
Nihon Seikeigeka Gakkai Zasshi; 1983 Jun; 57(6):617-28. PubMed ID: 6619626
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of genomic changes in a large series of malignant ovarian germ cell tumors--relation to clinicopathologic variables.
Kildal W; Kaern J; Kraggerud SM; Abeler VM; Sudbø J; Tropè CG; Lothe RA; Danielsen HE
Cancer Genet Cytogenet; 2004 Nov; 155(1):25-32. PubMed ID: 15527899
[TBL] [Abstract][Full Text] [Related]
18. Image analysis versus flow cytometry for DNA ploidy quantitation of solid tumors: a comparison of six methods of sample preparation.
Danque PO; Chen HB; Patil J; Jagirdar J; Orsatti G; Paronetto F
Mod Pathol; 1993 May; 6(3):270-5. PubMed ID: 8346174
[TBL] [Abstract][Full Text] [Related]
19. Value of deoxyribonucleic acid ploidy and nuclear morphometry for prediction of disease progression in renal cell carcinoma.
Ruiz-Cerdá JL; Hernández M; Gomis F; Vera CD; Kimler BF; O'Connor JE; Jiménez-Cruz F
J Urol; 1996 Feb; 155(2):459-65. PubMed ID: 8558635
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of nuclear morphometry and DNA ploidy status for detection of malignant and premalignant oral lesions: quantitative cytologic assessment and review of methods for cytomorphometric measurements.
Pektas ZO; Keskin A; Günhan O; Karslioğlu Y
J Oral Maxillofac Surg; 2006 Apr; 64(4):628-35. PubMed ID: 16546642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
